CN101885759B - 一种特异性结合猪繁殖与呼吸综合症病毒的多肽及其筛选方法和应用 - Google Patents
一种特异性结合猪繁殖与呼吸综合症病毒的多肽及其筛选方法和应用 Download PDFInfo
- Publication number
- CN101885759B CN101885759B CN 201010209009 CN201010209009A CN101885759B CN 101885759 B CN101885759 B CN 101885759B CN 201010209009 CN201010209009 CN 201010209009 CN 201010209009 A CN201010209009 A CN 201010209009A CN 101885759 B CN101885759 B CN 101885759B
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- phage
- prrsv
- screening method
- monoclines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 40
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 33
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 32
- 238000012216 screening Methods 0.000 title abstract description 23
- 238000000034 method Methods 0.000 title abstract description 17
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 title abstract 9
- 241000700605 Viruses Species 0.000 claims abstract description 26
- BNBQSLZMHBFEIV-TUSQITKMSA-N His-Trp-Trp Chemical group C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CN=CN1 BNBQSLZMHBFEIV-TUSQITKMSA-N 0.000 claims abstract description 4
- YXEYTHXDRDAIOJ-CWRNSKLLSA-N Ser-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CO)N)C(=O)O YXEYTHXDRDAIOJ-CWRNSKLLSA-N 0.000 claims abstract description 4
- OQSQCUWQOIHECT-YJRXYDGGSA-N Ser-Tyr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OQSQCUWQOIHECT-YJRXYDGGSA-N 0.000 claims abstract description 4
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 claims abstract description 3
- 238000009395 breeding Methods 0.000 claims description 14
- 230000001488 breeding effect Effects 0.000 claims description 14
- 208000011580 syndromic disease Diseases 0.000 claims description 14
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 13
- 230000009870 specific binding Effects 0.000 claims description 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 abstract description 6
- 238000001514 detection method Methods 0.000 abstract description 5
- 238000012163 sequencing technique Methods 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 239000003550 marker Substances 0.000 abstract description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 238000013016 damping Methods 0.000 description 11
- 239000012530 fluid Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 108010067902 Peptide Library Proteins 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 238000002823 phage display Methods 0.000 description 6
- 241001515965 unidentified phage Species 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000006180 TBST buffer Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 101710132601 Capsid protein Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101100175482 Glycine max CG-3 gene Proteins 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000000627 locus coeruleus Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- -1 nitronic acid-hydrochloric acid Chemical compound 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000856 sucrose gradient centrifugation Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010209009 CN101885759B (zh) | 2010-06-25 | 2010-06-25 | 一种特异性结合猪繁殖与呼吸综合症病毒的多肽及其筛选方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010209009 CN101885759B (zh) | 2010-06-25 | 2010-06-25 | 一种特异性结合猪繁殖与呼吸综合症病毒的多肽及其筛选方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101885759A CN101885759A (zh) | 2010-11-17 |
CN101885759B true CN101885759B (zh) | 2013-01-09 |
Family
ID=43071871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010209009 Active CN101885759B (zh) | 2010-06-25 | 2010-06-25 | 一种特异性结合猪繁殖与呼吸综合症病毒的多肽及其筛选方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101885759B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1139703A (zh) * | 1995-03-14 | 1997-01-08 | 阿克佐诺贝尔公司 | 在相同细胞中表达猪生殖呼吸综合症病毒多肽 |
CN1259141A (zh) * | 1997-05-06 | 2000-07-05 | 农业技术研究基金会 | 用于疫苗或诊断测试中的鉴定prrs病毒的肽序列的prrsv抗原位点 |
CN101184997A (zh) * | 2005-02-25 | 2008-05-21 | 艾德克斯实验室公司 | 用于检测抗猪繁殖呼吸综合征病毒抗体的肽 |
-
2010
- 2010-06-25 CN CN 201010209009 patent/CN101885759B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1139703A (zh) * | 1995-03-14 | 1997-01-08 | 阿克佐诺贝尔公司 | 在相同细胞中表达猪生殖呼吸综合症病毒多肽 |
CN1259141A (zh) * | 1997-05-06 | 2000-07-05 | 农业技术研究基金会 | 用于疫苗或诊断测试中的鉴定prrs病毒的肽序列的prrsv抗原位点 |
CN101184997A (zh) * | 2005-02-25 | 2008-05-21 | 艾德克斯实验室公司 | 用于检测抗猪繁殖呼吸综合征病毒抗体的肽 |
Also Published As
Publication number | Publication date |
---|---|
CN101885759A (zh) | 2010-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102928585B (zh) | 一种猪肺炎支原抗体检测试剂盒及其制备方法 | |
CN105112398A (zh) | 一种杂交瘤细胞的制备及其分泌的单抗与应用 | |
CN106188250A (zh) | 一种猪瘟病毒e2蛋白的抗原表位模拟肽及制备方法和应用 | |
CN103751773A (zh) | 稳定表达猪瘟病毒e0-e1-e2蛋白的重组bhk细胞系及其在制备猪瘟疫苗与诊断试剂中的应用 | |
CN104233474A (zh) | 一种合成的噬菌体展示纳米抗体文库及其应用 | |
CN1458280A (zh) | 两个人工合成prrs病毒多表位串联核苷酸序列及应用 | |
CN104193805B (zh) | 鸭坦布苏病毒囊膜e蛋白抑制肽及其应用 | |
CN101885759B (zh) | 一种特异性结合猪繁殖与呼吸综合症病毒的多肽及其筛选方法和应用 | |
CN104744572A (zh) | 禽和猪戊型肝炎病毒共有抗原、单克隆抗体和制备方法及应用 | |
CN101152570B (zh) | 一种猪瘟病毒表位疫苗及其制备方法 | |
CN102584952B (zh) | 一种丙型肝炎病毒f蛋白的抗原构象表位模拟肽及其应用 | |
CN102174091B (zh) | 截短表达鸭瘟病毒重组囊膜gI蛋白及其制备方法与应用 | |
CN101412750B (zh) | 三肽囊素特异性结合肽及筛选方法 | |
CN101186644B (zh) | H3型流感病毒血凝素空间构象模拟抗原表位及其应用 | |
CN105037499A (zh) | 利用噬菌体抗体库针对人组胺受体4(hr4)表位模拟肽筛选及其疫苗构建方法 | |
CN101893631A (zh) | 南芥菜花叶病毒的检测方法及专用试剂盒 | |
Tolf et al. | Characterization of polyclonal antibodies against the capsid proteins of Ljungan virus | |
CN101619093B (zh) | 具有促进成纤维细胞生长因子受体3活性的多肽及其筛选方法和应用 | |
CN102181402B (zh) | 高致病性猪繁殖与呼吸综合征病毒单克隆抗体及其制备 | |
CN100475836C (zh) | 间充质干细胞亲和肽的筛选与用途 | |
Zhou et al. | High throughput screening of scFv antibodies against viral hemorrhagic septicaemia virus by flow cytometry | |
CN100374460C (zh) | 含有与鸡传染性支气管炎病毒特异性结合短肽的噬菌体及应用 | |
CN102021124A (zh) | 对虾白斑综合征病毒vp37酵母表面展示与应用 | |
CN105017385A (zh) | 基于模拟人组胺受体4(hr4)表位的疫苗及其构建方法 | |
CN105277695A (zh) | 一种免疫磁微粒化学发光法HCMVpp65抗原检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NANJING TIANBANG BIO-INDUSTRY CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110815 Address after: Xiaolingwei Nanjing City, Jiangsu province 210014 Zhongling Street No. 50 Applicant after: National Center for Veterinary Biologicals Engineering Research Co-applicant after: NANJING TIANBANG BIO-INDUSTRY Co.,Ltd. Address before: Xiaolingwei Nanjing City, Jiangsu province 210014 Zhongling Street No. 50 Applicant before: National Center for Veterinary Biologicals Engineering Research |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Xiaolingwei Nanjing City, Jiangsu province 210014 Zhongling Street No. 50 Co-patentee after: Zhaofenghua Biotechnology (Nanjing) Co.,Ltd. Patentee after: National Center for Veterinary Biologicals Engineering Research Address before: Xiaolingwei Nanjing City, Jiangsu province 210014 Zhongling Street No. 50 Co-patentee before: NANJING TIANBANG BIO-INDUSTRY Co.,Ltd. Patentee before: National Center for Veterinary Biologicals Engineering Research |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200827 Address after: Nanjing City, Jiangsu province 210014 Zhongling Street No. 50 Co-patentee after: Zhaofenghua Biotechnology (Nanjing) Co.,Ltd. Patentee after: National Center for Veterinary Biologicals Engineering Research Co-patentee after: Zhaofenghua Biotechnology (Fuzhou) Co.,Ltd. Address before: Xiaolingwei Nanjing City, Jiangsu province 210014 Zhongling Street No. 50 Co-patentee before: Zhaofenghua Biotechnology (Nanjing) Co.,Ltd. Patentee before: National Center for Veterinary Biologicals Engineering Research |